Drug design is never easy, and few drug candidates make it through the development pipeline and into the medicine cabinet. Side effects loom large among potential bugaboos. In the Dec. 14 online edition of the leading scientific journal Nature, a UCSF laboratory research team now reports another unintended consequence of drugs targeted against enzymes, known as kinases, within the body.